Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma

Open access
Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., Ben-Sahra, I., Lago, C., Leva, G., Tiberi, L., Robert, G., Pouponnot, C., Bost, F., Mazure, N. M. · 2024 · Cell Death Discovery

Published version of a preprint

Abstract

Medulloblastoma (MB) is the most prevalent brain cancer in children. Four subgroups of MB have been identified; of these, Group 3 is the most metastatic. Its genetics and biology remain less clear than the other groups, and it has a poor prognosis and few effective treatments available. Tumor hypoxia and the resulting metabolism are known to be important in the growth and survival of tumors but, to date, have been only minimally explored in MB. Here we show that Group 3 MB tumors do not depend on the canonical transcription factor hypoxia-inducible factor-1α (HIF-1α) to mount an adaptive response to hypoxia. We discovered that HIF-1α is rendered inactive either through post-translational methylation, preventing its nuclear localization specifically in Group 3 MB, or by a low expression that prevents modulation of HIF-target genes. Strikingly, we found that HIF-2 takes over the role of HIF-1 in the nucleus and promotes the activation of hypoxia-dependent anabolic pathways. The exclusion of HIF-1 from the nucleus in Group 3 MB cells enhances the reliance on HIF-2’s transcriptional role, making it a viable target for potential anticancer strategies. By combining pharmacological inhibition of HIF-2α with the use of metformin, a mitochondrial complex I inhibitor to block respiration, we effectively induced Group 3 MB cell death, surpassing the effectiveness observed in Non-Group 3 MB cells. Overall, the unique dependence of MB cells, but not normal cells, on HIF-2-mediated anabolic metabolism presents an appealing therapeutic opportunity for treating Group 3 MB patients with minimal toxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41420-024-02100-5

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Group 3 MB are sensitive to oxygen variations and do not express HIF-1 target genes. a Schematic distribution of the different MB subgroups according to the vascular system based on [49]. b Heatmap of the RNA expression of genes from GSE85217 with 763 primary samples from MB patients from Group 3, Group 4, SHH Group and WNT Group MB [31]. The heatmap focused specifically on target genes of HIF-1. Expression of the genes was compared using Phantasus (v1.19.3). Median expression is represented for each group. p-values were obtained using the Limma differential expression. c–f (c) DAOY, (d) ONS-76, (e) HDMB-03 and (f) D-458 cells were incubated in 21%, 6% and 1% O2 for 24, 48 and 72 h. Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005 and ****p < 0.0001. g Comparison of cell viabilities (%) of DAOY, ONS-76, HDMB-03 and D-458 cells incubated for 72 h in 1% O2. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005 and ****p < 0.0001. h–k (f) DAOY, (g) ONS-76, (h) HDMB-03HDMB-03 and (i) D-458 cells were seeded at the same density and incubated in 21%, 6% and 1% O2 for 24, 48 and 72 h. The 2-way ANOVA is representative of at least three independent experiments. **p < 0.005, ***p < 0.0005 and ****p < 0.0001. l DAOY, ONS-76, HDMB-03, and D-458 cells were incubated in normoxia (Nx, 21% O2) for 24 h and hypoxia (Hx, 1% O2) for 24, 48 and 72 h. Cell lysates were analyzed by immunoblotting for HIF-1α and HIF-2α. Tubulin was used as a loading control. m, n Heatmap of the RNA expression of genes in DAOY, ONS-76, HDMB-03 and D-458 cells exposed to Nx or Hx, compared with PDX3 and PDX7 from Group 3 MB. The heatmap focused specifically on target genes of (m) HIF-1 and (n) HIF-2. Expression of the genes was compared using Phantasus (v1.19.3). p-values were obtained using the Limma differential expression.
Fig. 1 Group 3 MB are sensitive to oxygen variations and do not express HIF-1 target genes. a Schematic distribution of the different MB subgroups according to the vascular system based on [49]. b Heatmap of the RNA expression of genes from GSE85217 with 763 primary samples from MB patients from Group 3, Group 4, SHH Group and WNT Group MB [31]. The heatmap focused specifically on target genes of HIF-1. Expression of the genes was compared using Phantasus (v1.19.3). Median expression is represented for each group. p-values were obtained using the Limma differential expression. c–f (c) DAOY, (d) ONS-76, (e) HDMB-03 and (f) D-458 cells were incubated in 21%, 6% and 1% O2 for 24, 48 and 72 h. Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005 and ****p < 0.0001. g Comparison of cell viabilities (%) of DAOY, ONS-76, HDMB-03 and D-458 cells incubated for 72 h in 1% O2. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005 and ****p < 0.0001. h–k (f) DAOY, (g) ONS-76, (h) HDMB-03HDMB-03 and (i) D-458 cells were seeded at the same density and incubated in 21%, 6% and 1% O2 for 24, 48 and 72 h. The 2-way ANOVA is representative of at least three independent experiments. **p < 0.005, ***p < 0.0005 and ****p < 0.0001. l DAOY, ONS-76, HDMB-03, and D-458 cells were incubated in normoxia (Nx, 21% O2) for 24 h and hypoxia (Hx, 1% O2) for 24, 48 and 72 h. Cell lysates were analyzed by immunoblotting for HIF-1α and HIF-2α. Tubulin was used as a loading control. m, n Heatmap of the RNA expression of genes in DAOY, ONS-76, HDMB-03 and D-458 cells exposed to Nx or Hx, compared with PDX3 and PDX7 from Group 3 MB. The heatmap focused specifically on target genes of (m) HIF-1 and (n) HIF-2. Expression of the genes was compared using Phantasus (v1.19.3). p-values were obtained using the Limma differential expression.CC BY · PubMed Central
Fig. 2 HIF-1α is transcriptionally inactive in Group 3 MB. a DAOY, ONS-76, HDMB-03 and D-458 cells were seeded at the same density and incubated in Hx (1% O2) for 72 h. Cell lysates were analyzed by immunoblotting for HIF-1α. b HIF-1 protein was induced by hypoxia in ONS-76 and HDMB-03 cell lines. Subcellular fractionation was performed on the lysis of these cells and the nuclear fractions containing the protein of interest were subjected to 2D electrophoresis. The extracts were either analyzed in a Western blot with an anti-HIF-1α antibody or stained with Coomassie blue and sent to mass spectrometry (MS). The horizontal strip at 100 kDa was cut into four equal parts for MS analysis. c Sum intensity of HIF-1α and HIF-1β in both ONS-76 and HDMB-03 after MS. d Immunofluorescence labeling and merged images with HIF-1α (in green) and DAPI (in blue) for DAOY, ONS-76, HDMB-03 and D-458 cells incubated for 48 h in Hx. e DAOY, ONS-76, HDMB-03 and D-458 cells were seeded at the same density and incubated in Hx (1% O2) for 48 h. Subcellular fractionation was used to identify proteins in nuclei and cytoplasm. HSP90 was used as a loading control. f Immunofluorescence labeling and merged images with HIF-1α (in red) and DAPI (in blue) for ONS-76, and HDMB-03 cells incubated for 48 h in Hx in the absence or presence of UNC0642 (5 µM). g Graphic representation of Ca9, Oct4 and Mct1mRNA expression in ONS-76 and HDMB-03 cells incubated in hypoxia (Hx—1% O2) for 48 h. The 1-way ANOVA is representative of two independent experiments. h Graphic representation of NAA10 (Ard1) mRNA expression in DAOY, ONS-76, HDMB-03 and D-458 cells incubated in normoxia (Nx) for 24 h and hypoxia (Hx - 1% O2) for 48 h. The 2-way ANOVA is representative of four independent experiments. **p < 0.005 and ****p < 0.0001.
Fig. 2 HIF-1α is transcriptionally inactive in Group 3 MB. a DAOY, ONS-76, HDMB-03 and D-458 cells were seeded at the same density and incubated in Hx (1% O2) for 72 h. Cell lysates were analyzed by immunoblotting for HIF-1α. b HIF-1 protein was induced by hypoxia in ONS-76 and HDMB-03 cell lines. Subcellular fractionation was performed on the lysis of these cells and the nuclear fractions containing the protein of interest were subjected to 2D electrophoresis. The extracts were either analyzed in a Western blot with an anti-HIF-1α antibody or stained with Coomassie blue and sent to mass spectrometry (MS). The horizontal strip at 100 kDa was cut into four equal parts for MS analysis. c Sum intensity of HIF-1α and HIF-1β in both ONS-76 and HDMB-03 after MS. d Immunofluorescence labeling and merged images with HIF-1α (in green) and DAPI (in blue) for DAOY, ONS-76, HDMB-03 and D-458 cells incubated for 48 h in Hx. e DAOY, ONS-76, HDMB-03 and D-458 cells were seeded at the same density and incubated in Hx (1% O2) for 48 h. Subcellular fractionation was used to identify proteins in nuclei and cytoplasm. HSP90 was used as a loading control. f Immunofluorescence labeling and merged images with HIF-1α (in red) and DAPI (in blue) for ONS-76, and HDMB-03 cells incubated for 48 h in Hx in the absence or presence of UNC0642 (5 µM). g Graphic representation of Ca9, Oct4 and Mct1mRNA expression in ONS-76 and HDMB-03 cells incubated in hypoxia (Hx—1% O2) for 48 h. The 1-way ANOVA is representative of two independent experiments. h Graphic representation of NAA10 (Ard1) mRNA expression in DAOY, ONS-76, HDMB-03 and D-458 cells incubated in normoxia (Nx) for 24 h and hypoxia (Hx - 1% O2) for 48 h. The 2-way ANOVA is representative of four independent experiments. **p < 0.005 and ****p < 0.0001.CC BY · PubMed Central
Fig. 3 PT2385 sensitizes Group 3 MB viability in vitro and affects glycolysis. a DAOY, ONS-76, HDMB-03, and D-458 cells were incubated in Hx for 72 h in the absence (Control) or presence of PT2385 at 1-, 10-, and 20 µM. Cell viability (%) was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05, **p < 0.005 and ****p < 0.0001. b–e Glycolysis in the absence (Control) or presence of PT2385 of (b) HDMB-O3, (c) D-458, (d) DAOY and (e) ONS-76 cells in Hx (1% O2) for 24 h. ECAR was evaluated with the XF24 analyzer. Cells were deprived of glucose for 1 h, then glucose (G) and oligomycin (O) were injected at the indicated times. The graphs are representative of at least three independent experiments carried out in octuplicate. * p < 0.05, **p < 0.005 and **** p < 0.0001. f–i Respiratory control of (f) HDMB-O3, (g) D-458, (h) DAOY and (i) ONS-76 cells, cultured for 24 h in Hx (1% O2) in the absence (Control) or presence of PT2385. OCR was measured in real time with the XF24 analyzer. Cells were deprived of glucose for 1 h, then glucose (G), oligomycin (O), FCCP (F), and Rotenone + Antimycin A (R/A) were injected at the indicated times. The graphs are representative of at least three independent experiments carried out in octuplicate. * p < 0.05. j DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in Phx (6% O2) or Hx (1% O2) for 72 h in the absence (Control) or presence of Metformin (Metf). Cell number was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05, **p < 0.005 and ****p < 0.0001. k DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in Phx (6% O2) or Hx (1% O2) for 72 h in the absence (Control) or presence of Metformin (Metf). Cell viability (%) was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05 and **p < 0.005.
Fig. 3 PT2385 sensitizes Group 3 MB viability in vitro and affects glycolysis. a DAOY, ONS-76, HDMB-03, and D-458 cells were incubated in Hx for 72 h in the absence (Control) or presence of PT2385 at 1-, 10-, and 20 µM. Cell viability (%) was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05, **p < 0.005 and ****p < 0.0001. b–e Glycolysis in the absence (Control) or presence of PT2385 of (b) HDMB-O3, (c) D-458, (d) DAOY and (e) ONS-76 cells in Hx (1% O2) for 24 h. ECAR was evaluated with the XF24 analyzer. Cells were deprived of glucose for 1 h, then glucose (G) and oligomycin (O) were injected at the indicated times. The graphs are representative of at least three independent experiments carried out in octuplicate. * p < 0.05, **p < 0.005 and **** p < 0.0001. f–i Respiratory control of (f) HDMB-O3, (g) D-458, (h) DAOY and (i) ONS-76 cells, cultured for 24 h in Hx (1% O2) in the absence (Control) or presence of PT2385. OCR was measured in real time with the XF24 analyzer. Cells were deprived of glucose for 1 h, then glucose (G), oligomycin (O), FCCP (F), and Rotenone + Antimycin A (R/A) were injected at the indicated times. The graphs are representative of at least three independent experiments carried out in octuplicate. * p < 0.05. j DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in Phx (6% O2) or Hx (1% O2) for 72 h in the absence (Control) or presence of Metformin (Metf). Cell number was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05, **p < 0.005 and ****p < 0.0001. k DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in Phx (6% O2) or Hx (1% O2) for 72 h in the absence (Control) or presence of Metformin (Metf). Cell viability (%) was measured using an ADAM cell counter. The graphs are representative of at least three independent experiments carried out in octuplicate. *p < 0.05 and **p < 0.005.CC BY · PubMed Central
Fig. 4 PT2385/Metf combination is effective in vitro and induces Group 3 MB cell death. a, b DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in (a) Phx or (b) Hx for 72 h in the absence (Control) or presence of PT2385 (1- or 10- µM) and Metformin (Metf, 10 mM). Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005, ***p < 0.0005 and ****p < 0.0001. c DAOY, ONS-76, HDMB-03 and D-458 cells were transfected with a control siRNA (siCtl), an siRNA specific to HIF-1α (siHIF-1α) or an siRNA specific to HIF-2α (siHIF-2α)for 24 h. Cells were then incubated in hypoxia (Hx) for 72 h. Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of three independent experiments. *p < 0.05, ***p < 0.0005 and **** p < 0.0001. d–f Principal component analysis (PCA) scores plot in positive mode based on samples of (d) ONS-76, (e) HDMB-03 and (f) D-458 cells, subjected to 24 h of Hx (1% O2), comparing cells in the absence (Ctl) and presence of PT2385 (1 µM), Metf (10 mM) or both. g–i Steady-state metabolite profile of (g) ONS-76, (h) HDMB-03 and (i) D-458 cells subjected to hypoxia (Hx) for 48 h in the absence (Ctl), or presence of PT2385+Metf. Intracellular metabolites from three independent samples per condition were profiled by LC/MS-MS, and those significantly altered in treated cells, relative to control cells, are shown as row-normalized heatmaps ranked according to fold-change log2 (treated/untreated). j Schematic representation of the different major metabolic pathways impacted by PT2385 + Metf treatment in Group 3 MB versus ONS-76 (Non-Group 3 MB). k Three-dimensional structures at day 0 (D0) and day 11 (D11) obtained from confocal image series using IMARIS software; scale bars = 500 µm. l, m Quantification of (l) cell volume, and (m) cell area at day 1 and day 11. A ratio was calculated from day 11 to day 1. The 2-way ANOVA is representative of at least five different organoids. *p < 0.05, **p < 0.005 and ****p < 0.0001.
Fig. 4 PT2385/Metf combination is effective in vitro and induces Group 3 MB cell death. a, b DAOY, ONS-76, HDMB-03 and D-458 cells were incubated in (a) Phx or (b) Hx for 72 h in the absence (Control) or presence of PT2385 (1- or 10- µM) and Metformin (Metf, 10 mM). Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of at least three independent experiments. *p < 0.05, **p < 0.005, ***p < 0.0005 and ****p < 0.0001. c DAOY, ONS-76, HDMB-03 and D-458 cells were transfected with a control siRNA (siCtl), an siRNA specific to HIF-1α (siHIF-1α) or an siRNA specific to HIF-2α (siHIF-2α)for 24 h. Cells were then incubated in hypoxia (Hx) for 72 h. Cell viability (%) was measured using an ADAM cell counter. The 2-way ANOVA is representative of three independent experiments. *p < 0.05, ***p < 0.0005 and **** p < 0.0001. d–f Principal component analysis (PCA) scores plot in positive mode based on samples of (d) ONS-76, (e) HDMB-03 and (f) D-458 cells, subjected to 24 h of Hx (1% O2), comparing cells in the absence (Ctl) and presence of PT2385 (1 µM), Metf (10 mM) or both. g–i Steady-state metabolite profile of (g) ONS-76, (h) HDMB-03 and (i) D-458 cells subjected to hypoxia (Hx) for 48 h in the absence (Ctl), or presence of PT2385+Metf. Intracellular metabolites from three independent samples per condition were profiled by LC/MS-MS, and those significantly altered in treated cells, relative to control cells, are shown as row-normalized heatmaps ranked according to fold-change log2 (treated/untreated). j Schematic representation of the different major metabolic pathways impacted by PT2385 + Metf treatment in Group 3 MB versus ONS-76 (Non-Group 3 MB). k Three-dimensional structures at day 0 (D0) and day 11 (D11) obtained from confocal image series using IMARIS software; scale bars = 500 µm. l, m Quantification of (l) cell volume, and (m) cell area at day 1 and day 11. A ratio was calculated from day 11 to day 1. The 2-way ANOVA is representative of at least five different organoids. *p < 0.05, **p < 0.005 and ****p < 0.0001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. Brahimi-Horn M, Laferrière J, Mazure N & Pouysségur, J. Tumor angiogenesis. In: Marmé D & Fusenig N, editors. Springer; 2007. pp. 171–94.

Cited by

See all 9

Metadata

Authors
Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., Ben-Sahra, I., Lago, C., Leva, G., Tiberi, L., Robert, G., Pouponnot, C., Bost, F., & Mazure, N. M.
Affiliations
  • Inserm (FR)
  • Centre National de la Recherche Scientifique (FR)
  • University of Trento (IT)
Corresponding author
  • Contenti, J.
  • Mazure, N. M.
Venue
Cell Death Discovery
Published
2024-07-24
Volume
10
Issue
1
Pages
338-338
ISSN
2058-7716 (ISSN-L)
OpenAlex
W4400934698
Cited by
6
References
49
Citations by year
2026: 2 · 2025: 4
FWCI
1.20
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death Discovery (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • PubMed Central (submittedVersion)
  • HAL (submittedVersion)
  • HAL (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Northwestern University
  • Infrastructures en Biologie Santé et Agronomie
  • Institut National de la Santé et de la Recherche Médicale (U1065)
  • Fondation ARC pour la Recherche sur le Cancer
  • Ligue Contre le Cancer
  • China Scholarship Council
  • Centre National de la Recherche Scientifique
  • Associazione Italiana per la Ricerca sul Cancro
  • National Institutes of Health
  • Robert H. Lurie Comprehensive Cancer Center
  • National Cancer Institute (R00CA194192)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
medulloblastoma, Group 3 medulloblastoma, hypoxia, HIF-1α, HIF-2α, nuclear localization, anabolic metabolism, metformin, mitochondrial complex I inhibition, HIF-2α inhibition, pediatric brain tumors, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma. https://app.cochat.ai/papers/10.1038/s41420-024-02100-5
The paper
Contenti, J., Guo, Y., Larcher, M., Mirabal-Ortega, L., Rouleau, M., Irondelle, M., Tiroille, V., Mazzu, A., Duranton-Tanneur, V., Pedeutour, F., Ben-Sahra, I., Lago, C., Leva, G., Tiberi, L., Robert, G., Pouponnot, C., Bost, F., & Mazure, N. M. (2024). HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma. Cell Death Discovery. https://doi.org/10.1038/s41420-024-02100-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.